通策医疗: 通策医疗股份有限公司2024年年度股东会决议公告

Meeting Overview - The shareholders' meeting of Tongce Medical Co., Ltd. was held on June 5, 2025, at the company's headquarters in Hangzhou [1] - The meeting was convened by the board of directors and chaired by Chairwoman Wang Yi, following legal and procedural requirements [1] Voting Results - All proposed resolutions were approved by the shareholders, with significant support from A-shareholders [2][3] - The voting results for the annual report showed 99.7649% approval from A-shareholders, with only 0.1801% against and 0.0550% abstaining [1] - The cash dividend proposal received 99.7415% approval, with 0.1908% against and 0.0677% abstaining [2] Shareholder Participation - The meeting included participation from various shareholder categories, with 100% approval from major shareholders holding over 5% of shares [2] - Among shareholders holding less than 1%, 89.2999% voted in favor of the proposals, indicating strong support from smaller investors [2] Legal Compliance - The meeting was witnessed by lawyers from Zhejiang Tian Ce Law Firm, confirming that the meeting's procedures and voting were in compliance with legal and regulatory standards [3]